Canada Pension Plan Investment Board’s Kyntra Bio KYNB Stock Holding History

Canada Pension Plan Investment Board’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,708	Closed	-$1.73M	–	1191
2020 Q2	$1.73M	Sell	1,708 -495	-22%	-$460K	﹤0.01%	780
2020 Q1	$1.91M	Sell	2,203 -261	-11%	-$259K	0.01%	737
2019 Q4	$2.64M	Sell	2,464 -1,661	-40%	-$1.7M	0.01%	786
2019 Q3	$3.81M	Sell	4,125 -1,379	-25%	-$1.51M	0.01%	722
2019 Q2	$6.22M	Buy	5,504 +3,164	+135%	+$3.46M	0.01%	673
2019 Q1	$3.18M	Buy	2,340 +496	+27%	+$673K	0.01%	900
2018 Q4	$2.13M	Buy	+1,844	New	+$2.07M	﹤0.01%	955
2018 Q2	–	Sell	-2,008	Closed	-$2.32M	–	1255
2018 Q1	$2.32M	Buy	+2,008	New	+$2.64M	﹤0.01%	953

Other funds holding KYNB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Canada Pension Plan Investment Board's KYNB Position: Q3 2020 in Review

Canada Pension Plan Investment Board sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 1,708 shares — an estimated $1.73M sold.

Canada Pension Plan Investment Board first reported a position in KYNB in Q1 2018 and held it in 8 quarters. The position peaked at $6.22M in Q2 2019. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

Canada Pension Plan Investment Board reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
Canada Pension Plan Investment Board sold 1,708 Kyntra Bio shares in Q3 2020, an estimated $1.73M.
Canada Pension Plan Investment Board first reported a position in Kyntra Bio in Q1 2018 and held it in 8 quarters.
Canada Pension Plan Investment Board's Kyntra Bio position peaked at $6.22M in Q2 2019.
208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2020, filed 12 Nov 2020.